iSpecimen Inc. Quarterly Costs and Expenses in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
iSpecimen Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2020 to Q2 2024.
  • iSpecimen Inc. Costs and Expenses for the quarter ending June 30, 2024 was $5.05M, a 2.73% decline year-over-year.
  • iSpecimen Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $20.8M, a 3.32% decline year-over-year.
  • iSpecimen Inc. annual Costs and Expenses for 2023 was $21.1M, a 2.47% increase from 2022.
  • iSpecimen Inc. annual Costs and Expenses for 2022 was $20.6M, a 20.7% increase from 2021.
  • iSpecimen Inc. annual Costs and Expenses for 2021 was $17.1M, a 61.1% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $20.8M $5.05M -$142K -2.73% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $20.9M $5.29M -$202K -3.68% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $21.1M $5.45M +$343K +6.72% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $20.8M $4.97M -$713K -12.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $21.5M $5.19M +$263K +5.35% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $21.2M $5.49M +$616K +12.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $20.6M $5.1M +$559K +12.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $20M $5.68M +$1.51M +36.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $18.5M $4.92M +$491K +11.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $18M $4.88M +$971K +24.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $17.1M $4.54M Oct 1, 2021 Dec 31, 2021 10-K/A 2023-03-30
Q3 2021 $4.18M +$1.2M +40.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $4.43M +$2.62M +145% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $3.91M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 $2.97M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.81M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.